Movicol and Cancidas drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Cancidas (caspofungin acetate). Common drug interactions include electrocardiogram qt prolonged among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Movicol and Cancidas. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Cancidas?

Cancidas has active ingredients of caspofungin acetate. eHealthMe is studying from 4,879 Cancidas users. Check the latest studies of Cancidas.

On Jul, 14, 2026

22 people who take Movicol and Cancidas together, and have interactions are studied.

What are the common drug interactions of Movicol and Cancidas, by gender? *:

female:

Electrocardiogram qt prolonged
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Enterobacter infection (infection caused by bacteria of the family enterobacteriaceae)
Facial paralysis (loss of function of face muscle)
Febrile neutropenia (fever with reduced white blood cells)
General physical health deterioration (weak health status)
Granulomatous liver disease (a mass of inflamed granulation tissue of liver)
Hallucination (an experience involving the perception of something not present)
Inflammation
Lung infection

male:

Acute respiratory failure
Pyrexia (fever)
Hypotension (abnormally low blood pressure)
Interstitial lung disease
Metapneumovirus infection (infection with human metapneumovirus)
Pulmonary embolism (blockage of the main artery of the lung)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Cytomegalovirus infection
Cytomegalovirus test positive
Pneumonia bacterial (pneumonia associated with bacterial infection)

What are the common drug interactions of Movicol and Cancidas, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Electrocardiogram qt prolonged
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)

50-59:

n/a

60+:

Acute respiratory failure
Pyrexia (fever)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Hypotension (abnormally low blood pressure)
Interstitial lung disease
Metapneumovirus infection (infection with human metapneumovirus)
Pulmonary embolism (blockage of the main artery of the lung)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Cytomegalovirus infection
Cytomegalovirus test positive

What are the existing conditions these people have? *

Diabetes: 9 people, 40.91%
Empyema (collection of pus in a cavity in the body): 8 people, 36.36%
Fever: 7 people, 31.82%
Pain: 6 people, 27.27%
Multiple Myeloma (cancer of the plasma cells): 5 people, 22.73%
Back Pain: 5 people, 22.73%
Bone Pain: 5 people, 22.73%
Hypotension (abnormally low blood pressure): 5 people, 22.73%
Cytomegalovirus Infection: 5 people, 22.73%
Pulmonary Embolism (blockage of the main artery of the lung): 5 people, 22.73%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and Cancidas?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously